JVDI Advertisement
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guedes, R.
Right arrow Articles by Winkelman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guedes, R.
Right arrow Articles by Winkelman, N.
Journal of Veterinary Diagnostic Investigation, Vol 14, Issue 6, 528-530
Copyright © 2002 by American Association of Veterinary Laboratory Diagnosticians

Articles

Validation of an immunoperoxidase monolayer assay as a serologic test for porcine proliferative enteropathy

RM Guedes, CJ Gebhart, J Deen, and NL Winkelman

Department of Veterinary PathoBiology, University of Minnesota, Saint Paul 55108, USA.

The sensitivity and specificity of an immunoperoxidase monolayer assay (IPMA) was evaluated in a blind serologic study of a group of disease-free pigs and a group of pigs experimentally infected with intestinal homogenate containing Lawsonia intracellularis organisms. Sixty pigs from the control group were kept in the source farm, and another 60 animals were transferred to an isolation unit aid challenged intragastrically. All animals were bled before and 21 days after challenge. Fecal samples were collected on the same dates. The IPMA results were tested for sensitivity and specificity in a 2 x 2 table using the challenged and nonchallenged status as gold standard. Sensitivity and specificity were evaluated for different cutoff points (serum dilutions). Specificities of 100% were obtained for all the serum dilutions tested (1:15, 1:30, 1:60, and 1:120). The sensitivity levels were 90.7%, 88.9%, 81.5%, and 75.9% for the serum dilutions 1:15, 1:30, 1:60, and 1:120, respectively. The sensitivity of the dilution 1:15 was slightly, but not significantly, higher than the dilution currently used as the cutoff point (1:30). Cross-reactivity of the IPMA test was evaluated using sera from pigs experimentally inoculated with Brachyspira pilosicoli and various Campylobacter species. All these samples were negative. Sera samples from 3 porcine proliferative enteropathy known negative populations, 40 growing pigs from 2 commercial farms and a group of 6 cesarean-derived and colostrum-deprived pigs, also tested negative by IPMA. The IPMA serologic test with the cutoff point of 1:30 showed specificity of 100% and sensitivity close to 90% and, therefore, is an appropriate diagnostic test for herd screening but not for diagnosing PPE on the individual level.


This article has been cited by other articles:


Home page
 Vet Rec.Home page
N. Pusterla, J. Collier, S. M. Mapes, S. Wattanaphasak, and C. Gebhart
Effects of administration of an avirulent live vaccine of Lawsonia intracellularis on mares and foals
Vet Rec., June 20, 2009; 164(25): 783 - 785.
[Full Text] [PDF]

Home page
 Vet Rec.Home page
N. Pusterla, J. C. Higgins, P. Smith, S. Mapes, and C. Gebhart
Epidemiological survey on farms with documented occurrence of equine proliferative enteropathy due to Lawsonia intracellularis
Vet Rec., August 2, 2008; 163(5): 156 - 158.
[Full Text] [PDF]

Home page
 jvdiHome page
S. Wattanaphansak, T. Asawakarn, C. J. Gebhart, and J. Deen
Development and validation of an enzyme-linked immunosorbent assay for the diagnosis of porcine proliferative enteropathy
J Vet Diagn Invest, March 1, 2008; 20(2): 170 - 177.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association of Veterinary Laboratory Diagnosticians, Inc.